Source: Eur Respir J, 52 (2) 1701898; 10.1183/13993003.01898-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Olivier Brugière, Antoine Roux, Jerome Le Pavec, Deborah Sroussi, François Parquin, Pauline Pradère, Clairelyne Dupin, Vincent Bunel, Gisele Mourin, Gilles Jebrak, Gaëlle Dauriat, Yves Castier, Pierre Mordant, Brice Lortat-Jacob, Sylvain Jean-Baptiste, Herve Mal, Caroline Suberbielle, Chantal Gautreau, Sophie Caillat-Zucman, Aurélie Cazes, Gabriel Thabut, Jean-Luc Taupin. Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome. Eur Respir J, 52 (2) 1701898; 10.1183/13993003.01898-2017

Member's Comments

No comment yet.

Related content which might interest you: Pre-transplant soluble CD30 is a stronger predictor of BOS than anti-HLA antibodies occurring after lung transplantation Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunction Source: Eur Respir J, 54 (5) 1900847; 10.1183/13993003.00847-2019 Year: 2019 Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation Source: Eur Respir J, 50 (5) 1701248; 10.1183/13993003.01248-2017 Year: 2017 The impact of pre-transplant donor specific anti-HLA antibodies (DSAs) on lung transplant outcome: A single center experience Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome Source: Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020 Year: 2021 Intragraft donor-specific antibodies and lung transplantation Source: Eur Respir J, 54 (5) 1901937; 10.1183/13993003.01937-2019 Year: 2019 Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD) Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Significance of anti-HLA immunization in lung transplantation Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations Year: 2011 High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003 The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 178s Year: 2004 Serum IgG and IgA antibodies to chramydia pneumoniae and severity of emphysema Source: Eur Respir J 2004; 24: Suppl. 48, 44s Year: 2004 Antinuclear antibodies in interstitial lung diseases: Prevalence and predictive factors Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Altered Fc galactosylation in IgG4 is a potential serum marker for chronic lung disease Source: ERJ Open Res, 4 (3) 00033-2018; 10.1183/23120541.00033-2018 Year: 2018 KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Antinucleosome autoantibody in a patient with sarcoidosis and antiphospholipid antibodies Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010 Age is a predictor of efficacy of monoclonal antibodies in allergic severe asthma Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Detection of serum anti-endothelial cell antibodies (AECA) in COPD rats Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Long-term outcome of 53 patients with anti-Jo-1 antibody-positive interstitial lung disease Source: International Congress 2017 – Rare diseases Year: 2017 Use of immune cell function assay in immune surveillance of lung transplant recipients: Correlations with clinical outcome and other immune assays Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012